Company Overview of Pear Tree Pharmaceuticals, Inc.
Pear Tree Pharmaceuticals, Inc. operates as a development stage pharmaceutical company which engages in the development and commercialization of pharmaceuticals for aging women. It offers products that treat and prevent diseases, symptoms, and conditions associated with menopause and cancer chemotherapy. Its portfolio includes PT-200 for urogenital atrophy associated with menopause; PT-201 for urinary symptoms associated with menopause; and PT-101 for urogenital atrophy associated with menopause in women with an increased risk for breast cancer. The company was founded in 2007 and is based in Cambridge, Massachusetts.
125 CambridgePark Drive
Cambridge, MA 02140
Founded in 2007
Key Executives for Pear Tree Pharmaceuticals, Inc.
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Pear Tree Pharmaceuticals, Inc., please visit www.peartreerx.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.